0001437749-23-031329.txt : 20231109
0001437749-23-031329.hdr.sgml : 20231109
20231109194103
ACCESSION NUMBER: 0001437749-23-031329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231109
FILED AS OF DATE: 20231109
DATE AS OF CHANGE: 20231109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALAM JOHN J
CENTRAL INDEX KEY: 0001197014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 231394265
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CervoMed Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA
STREET 2: SUITE 424
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 744-4400
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA
STREET 2: SUITE 424
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Diffusion Pharmaceuticals Inc.
DATE OF NAME CHANGE: 20160115
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-11-09
0001053691
CervoMed Inc.
CRVO
0001197014
ALAM JOHN J
20 PARK PLAZA, SUITE 424
BOSTON
MA
02116
1
1
1
CEO & President
0
Common Stock
2023-11-09
4
G
0
12500
0
D
729539
D
Common Stock
732039
I
By Spouse
Represents one or more bona fide gifts of the Issuer's Common Stock by the Reporting Person (such shares, the "Gift Shares") to certain friends and/or family members who are not immediate family members sharing the same household. In accordance with the terms of the lock-up agreement, dated March 30, 2023, by and between the Reporting Person and the Issuer (the "Lock-Up Agreement"), in connection with the transfer(s) of the Gift Shares, each transferee will be subject to an agreement pursuant to which the transferee agrees not to further transfer the Gift Shares prior to August 16, 2024, subject to certain exceptions, on terms substantially similar to those set forth in the Lock-Up Agreement. Following the transaction, the Reporting Person has neither investment control over nor a pecuniary interest in the Gift Shares.
Consists of shares of the Issuer's common stock held by Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ William R. Elder, attorney-in-fact for the Reporting Person
2023-11-09